For: | Low A, Love M, Walt R, Kane K, Eksteen B, Goh J. Understanding of chemoprophylaxis and concordance in inflammatory bowel disease. World J Gastroenterol 2010; 16(5): 578-582 [PMID: 20128025 DOI: 10.3748/wjg.v16.i5.578] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/578.htm |
Number | Citing Articles |
1 |
Seong-Joon Koh, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Dae Woo Kim, Joo Sung Kim. Matricellular protein periostin promotes colitis-associated colon tumorigenesis in mice. Carcinogenesis 2019; 40(1): 102 doi: 10.1093/carcin/bgy120
|
2 |
Nick E Burr, Mark A Hull, Venkataraman Subramanian. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?. World Journal of Gastroenterology 2016; 22(13): 3679-3686 doi: 10.3748/wjg.v22.i13.3679
|
3 |
Affifa Farrukh, John F Mayberry. Surveillance for colorectal cancer and chemoprevention in ulcerative and Crohn's colitis: The need for clinical strategies to increase effectiveness. JGH Open 2019; 3(5): 370 doi: 10.1002/jgh3.12173
|
4 |
Nick E. Burr, Mark A. Hull, Venkataraman Subramanian. Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2017; 51(3): 247 doi: 10.1097/MCG.0000000000000498
|